Literature DB >> 6391663

Teniposide: a review of 12 years of experience.

P J O'Dwyer, M T Alonso, B Leyland-Jones, S Marsoni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391663

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  17 in total

Review 1.  Do anticancer agents reach the tumor target in the human brain?

Authors:  M G Donelli; M Zucchetti; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Phase II study of teniposide in advanced breast cancer.

Authors:  J Boas; D Rasmussen; O P Hansen; S A Engelholm; P Dombernowsky
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Teniposide is not effective in chronic lymphocytic leukemia.

Authors:  V Zagonel; U Tirelli; A Veronesi; E Galligioni; S Tumolo; M Roncadin; A Carbone; E Grigoletto
Journal:  Blut       Date:  1986-01

5.  Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).

Authors:  A Y Chang; Z N Tu; J L Smith; P Bonomi; T J Smith; P H Wiernik; R Blum
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

Review 6.  Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.

Authors:  J J Holthuis
Journal:  Pharm Weekbl Sci       Date:  1988-06-17

7.  2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells.

Authors:  P R Andreassen; R L Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.

Authors:  H Roed; L L Vindelov; I J Christensen; M Spang-Thomsen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial.

Authors:  E B Cox; C L Vogel; J T Carpenter; M Raney
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

Review 10.  The clinical pharmacology of etoposide and teniposide.

Authors:  P I Clark; M L Slevin
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.